vorasidenib
servier
['vorasidenib']
in patients with #gliomas bearing idh1/2 mutations, the brain barrier-crossing oral drug vorasidenib kept tumors at bay, and could be used instead of more toxic chemotherapies and radiation. #asco23 #onctwitter 
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.